SPRYD4

Model summary

A nuclear, SPRY-domain scaffold that organizes protein–protein assemblies to promote polyubiquitination. Its beta-sandwich architecture creates a high-affinity binding platform that recruits ubiquitination machinery and substrates in the nucleus, enhancing chain assembly on regulatory targets and coupling nuclear proteostasis to transcriptional control.

Predicted Gene Ontology terms

1. 01

   I begin with the InterPro architecture.

   The core of the protein is a continuous B30.2/SPRY module: IPR001870 (B30.2/SPRY domain, residues 12–206) forms the scaffold that dominates the sequence and is reinforced by multiple SPRY/B30.2 annotations—IPR003879 (Butyrophylin-like, SPRY domain, residues 28–45), IPR003879 (Butyrophylin-like, SPRY domain, residues 70–94), IPR003877 (SPRY domain, residues 85–204), and IPR003879 motifs at residues 142–166 and 172–190. This layered annotation indicates a canonical SPRY beta-sandwich fold that specializes in avid, selective protein–protein interactions rather than catalysis. The B30.2/SPRY superfamily context is captured by IPR043136 (B30.2/SPRY domain superfamily, residues 19–198), and the overall beta-sandwich topology is further supported by IPR013320 (Concanavalin A-like lectin/glucanase domain superfamily, residues 30–202), which signals a jelly-roll fold that stabilizes ligand-binding grooves. Finally, IPR050617 (E3 ubiquitin-protein ligases and FN3/SPRY domain-containing proteins, residues 28–205) ties this SPRY platform to ubiquitin pathway components, indicating that the architecture is tuned to recruit or organize ubiquitination machinery.

2. 02

   This domain architecture causally dictates molecular function.

   The uninterrupted SPRY platform lacks catalytic residues for ubiquitin transfer but is optimized for avid, multivalent binding. That explains GO:0005515 protein binding as the primary molecular function: the B30.2/SPRY fold creates a high-affinity interaction surface that captures substrates and E3/E2 modules. The IPR050617 family association with ubiquitin ligases suggests that the SPRY scaffold nucleates or stabilizes ubiquitination assemblies rather than performing the chemistry itself.

3. 03

   From this binding-centric function, the biological process follows.

   By assembling and positioning ubiquitination machinery, the protein promotes chain assembly on targets—consistent with GO:0000209 protein polyubiquitination. The SPRY platform’s role is to increase local concentration and orientation of E2–E3–substrate complexes, thereby enhancing polyubiquitin chain formation and turnover.

4. 04

   Cellular location is inferred from function and fold usage.

   SPRY-domain adaptors frequently operate in nuclear pathways that regulate transcription and proteostasis. The absence of transmembrane features and the propensity of SPRY scaffolds to coordinate chromatin-associated complexes support a soluble nuclear role, aligning with GO:0005634 nucleus. Nuclear residence is mechanistically coherent: nuclear ubiquitination controls transcriptional regulators and DNA-associated factors that require timely turnover.

5. 05

   These elements together suggest a mechanistic model: a nuclear SPRY scaffold that binds multiple partners to drive polyubiquitination.

   It likely forms transient assemblies with ubiquitin E3 ligases and their E2 conjugating enzymes, positioning substrates for efficient chain elongation. I hypothesize that it engages nuclear E3 modules and proteasome-shuttle factors—such as cullin–RING ligases, HECT-type ligases, and RAD23/UBQLN adaptors—to coordinate substrate selection and handoff. In this framework, the protein acts as a specificity hub: its B30.2/SPRY architecture concentrates ubiquitination components in the nucleus, thereby tuning transcriptional and proteostatic pathways through regulated polyubiquitin assembly.